Hybrid PET MR Neuroimaging A Comprehensive Approach instant download
Hybrid PET MR Neuroimaging A Comprehensive Approach instant download
Approach download
https://ebookmeta.com/product/hybrid-pet-mr-neuroimaging-a-
comprehensive-approach/
https://ebookmeta.com/product/hybrid-pet-mr-neuroimaging-a-
comprehensive-approach-ana-m-franceschi-editor-dinko-franceschi-
editor/
https://ebookmeta.com/product/understandable-statistics-concepts-
and-methods-13th-edition-charles-henry-brase/
American Lit 101 4th Edition Brianne Keith
https://ebookmeta.com/product/american-lit-101-4th-edition-
brianne-keith/
https://ebookmeta.com/product/temple-of-cocidius-a-monster-girl-
harem-adventure-serial-part-5-1st-edition-maxx-whittaker/
https://ebookmeta.com/product/midknight-1st-edition-ann-denton/
https://ebookmeta.com/product/alpha-s-fire-shifter-ops-4-1st-
edition-renee-rose-lee-savino/
https://ebookmeta.com/product/strategic-management-during-a-
pandemic-1st-edition-vikas-kumar-editor/
Heart Failure: An Essential Clinical Guide 1st Edition
Edited By Andreas P. Kalogeropoulos & Hal A. Skopicki
And Javed Butler & Edited By Andreas P. Kalogeropoulos
https://ebookmeta.com/product/heart-failure-an-essential-
clinical-guide-1st-edition-edited-by-andreas-p-kalogeropoulos-
hal-a-skopicki-and-javed-butler-edited-by-andreas-p-
kalogeropoulos/
Ana M. Franceschi
Dinko Franceschi
Editors
Hybrid PET/MR
Neuroimaging
A Comprehensive Approach
123
Hybrid PET/MR Neuroimaging
Ana M. Franceschi • Dinko Franceschi
Editors
© The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerland AG 2022
This work is subject to copyright. All rights are solely and exclusively licensed by the Publisher, whether the whole or
part of the material is concerned, specifically the rights of translation, reprinting, reuse of illustrations, recitation,
broadcasting, reproduction on microfilms or in any other physical way, and transmission or information storage and
retrieval, electronic adaptation, computer software, or by similar or dissimilar methodology now known or hereafter
developed.
The use of general descriptive names, registered names, trademarks, service marks, etc. in this publication does not
imply, even in the absence of a specific statement, that such names are exempt from the relevant protective laws and
regulations and therefore free for general use.
The publisher, the authors, and the editors are safe to assume that the advice and information in this book are believed
to be true and accurate at the date of publication. Neither the publisher nor the authors or the editors give a warranty,
expressed or implied, with respect to the material contained herein or for any errors or omissions that may have been
made. The publisher remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This Springer imprint is published by the registered company Springer Nature Switzerland AG
The registered company address is: Gewerbestrasse 11, 6330 Cham, Switzerland
Foreword
I am excited and honored to write the foreword for the book Hybrid PET/MR Neuroimaging:
A Comprehensive Approach edited by the father and daughter team, Dinko and Ana Franceschi
(my trainee!). Dinko has 30 years’ experience in nuclear medicine and has clearly recognized
hybrid PET-MRI is an important new technology that will completely change our practice
futures. I helped train Ana in neuroradiology and PET-MRI – in just a few years, Ana has
become a recognized early expert and champion for using this technology in routine clinical
practice, first in the New York City area, and now at national meetings for neuroradiology and
nuclear medicine. Ana and Dinko have collaborated with established and emerging leaders in
this new field to cover the expanding scope and impact of hybrid PET-MRI. My only complaint
is that I actually needed this book in the summer of 2012! Now there will be an excellent
resource for physicians with different training and clinical backgrounds who are interested in
learning more about the utility and interpretation of hybrid PET-MRI for neurological
diseases.
My own early personal experience with PET-MRI may be instructive to readers interested
in getting started since NYU was one of the first programs to use PET-MRI for clinical prac-
tice – i.e. what it was like in the “old days” before this helpful book was available. I suspect
many of the chapter authors can tell similar stories. When I arrived at NYU in August 2012
fresh out of fellowship, we had just installed a hybrid PET-MRI scanner in the main outpatient
radiology facility. Yvonne Lui, my section chief, asked me to be the neuroradiology liaison for
PET-MRI clinical and research studies. After neuroradiology fellowship training, I was quite
familiar with the role of MRI in the clinical management of epilepsy and dementia, was an
“authorized user,” and had decent trainee-level experience with FDG PET for cancer imaging
(maybe 50 cases). My proudest accomplishment in nuclear medicine though may have been
my autographed copy of Mettler’s textbook obtained when he visited UCSF during boards
preparation. At that point, I had read three FDG PET brain studies in my “career” – one of
those was for the radiology board exam in a hotel room in Louisville in 2011 and to this day I
think I failed that case! We were unsure how to apply this new technology, but started using a
research protocol that allowed us to pay for a cab and transport patients after their routine FDG
PET-CT at the NYU cancer center across midtown Manhattan to be reimaged on the PET-MRI
scanner at the radiology outpatient facility on First Avenue using the original decaying FDG
dose.
It began as a trickle of patients. Over the next 2 years, I learned on the job how to really
analyze and interpret FDG PET from Kent Friedman, chief of NYU nuclear medicine. Kent
and I reviewed the MRI and FDG PET images together once a week in a dual-readout format
and prepared two separate reports. We were lucky not to have turf wars between sections and
combined our expertise to interpret these studies. It was a time of discovery as we encountered
real patients that forgot to read the textbooks before they showed up for imaging and we
always had lots of questions – it was perhaps my limited knowledge of the FDG PET literature
in the 1970–1980s that led me to “rediscover” key features for PET interpretation in epilepsy
patients. After only seven patients had consented to both PET-CT and PET-MRI studies, the
NYU level IV epilepsy center stopped ordering PET-CT for their patients and switched exclu-
sively to PET-MRI studies. Eighteen months later in summer 2014, we opened the “ floodgates”
v
vi Foreword
and agreed to use this new technology to image patients with suspected cognitive impairment
from the NYU Pearl Barlow memory and aging center. Our volume immediately doubled, then
doubled again over the next 18 months. Today, we typically interpret 25–30 clinical neurora-
diology PET-MRI studies a week (~1200 per year) – a volume dominated by cognitive impair-
ment workup, but we also image patients weekly for epilepsy, autoimmune encephalitis, brain,
and neck tumors. Last time I checked in 2016, overall brain PET FDG volume was up 300%
from 2012. We were one of the few sites to contribute to the original IDEAS study with hybrid
PET-MRI data using amyloid tracers and routinely use multiple additional radiotracers in clini-
cal practice and research (e.g., Dotatate, Tau, and TSPO tracers). I would predict that the recent
FDA approval of Aduhelm, the amyloid-lowering immunotherapy from Biogen, also may
increase our volume substantially.
Hybrid PET-MRI has changed our practice and actually changed the way I interpret MRI
even without simultaneous PET. Over time those subtle MRI calls on epilepsy studies I was
wary of mentioning in a conference at a well-known level IV epilepsy center for fear of my life
were corroborated by the simultaneously acquired FDG PET, then subsequent intracranial
EEG and surgical pathology. It is quite humbling to realize that subtle hippocampal sclerosis
you were so excited to detect was just the tip of the iceberg in epilepsy patients and many of
those “icebergs” were not even detectable with state-of-the-art MRI sequences. Conversely,
MRI findings redirected us to recognize subtle extra-temporal FDG abnormalities we missed
on an initial review that correlated well with semiology, EEG, and eventually surgical pathol-
ogy. NYU referrers became very reliant on the PET-MRI reads we provide. Next Monday at
our weekly multidisciplinary conference all four epilepsy patients considering surgery will
have had hybrid FDG PET-MRI first. We had a similar experience changing the workup for
neurodegenerative disease – instead of equivocating on ambiguous FDG PET findings or using
MRI only to assess white matter disease, mass, and hydrocephalus, we started providing con-
stellations of multimodal imaging findings to support workup for specific diagnoses.
Particularly for dementia, we observed a changing role for radiologists in the triage of patients.
Busy general neurology referrers that may not have expertise or time on the initial visit to
distinguish the causes for word-finding difficulty would change their follow-up evaluations
and management based on our PET-MRI report. Conversely, experts in primary progressive
aphasia would use such reports to focus their practice, time, and resources. In epilepsy, neuro-
degenerative disease, and autoimmune encephalitis, you learn quickly you cannot hide from
the limits of sensitivity and specificity for MRI findings we proudly teach residents once you
see the much more obvious findings on simultaneously acquired FDG PET. Previous groups
had shown the advantages of reinterpreting separately acquired PET and MRI together in epi-
lepsy and dementia respectively [1, 2] – we were just turning that into daily clinical practice
with a single efficient imaging session that patients, referrers, and the interpreting radiologists
clearly preferred. I expect this phenomenon to continue and to expand to other common neu-
rologic diseases as the technology and radiochemistry develop.
The biggest challenge to this new paradigm is finding physicians comfortable reading these
studies by themselves, but this also results in the most powerful diagnostic confidence and
efficient workflow. Our rapidly increasing volume showed quite clearly that hybrid PET-MRI
was addressing an unmet need for our referrers – I would come back from 2 weeks of relaxing
summer vacation with 30–40 cases waiting for me! An individual reader needs to be knowl-
edgeable in several diverse areas that Ana, Dinko, and their chapter authors have made sure are
well-covered by this book – neuroanatomy, PET physics and artifacts, potential compromises
in imaging physics associated with hybrid PET-MRI (e.g., attenuation correction), FDG and
various common radiotracers, software visualization tools and limitations. In 2013–15, I’m not
convinced anyone came out of training with that complete skillset. Faculty with dual fellow-
ship training in nuclear medicine and neuroradiology were as common as unicorns with zebra
stripes (that is now changing). Very few nuclear medicine fellowship training programs are
exposing trainees to even 50 FDG PET brain studies per year. I feel there remains a strong need
and responsibility to train more people, and this book will be a tremendous help to that p rocess.
Foreword vii
Every year the NYU fellowship program trains 6–7 fellows to read PET-MRI with each fellow
reading more than 100 cases during the year. Some may argue the PET is a waste of time for
“regular” neuroradiologists, but it teaches them humility regarding the limitations of MRI and
makes them better readers. Often we would see something or a question would come up during
read up that I did not have a good answer for or could easily find in the PET literature – this
book offers an up-to-date comprehensive resource for those frequent situations! In a messianic
tone, I always foretell to the fellows that behind the current noise of deep learning, PET-MRI
will revolutionize our field and that if they plan to practice for more than 10 years they will be
reading PET-MRI studies. Ana Franceschi was the fellow who actually listened to me!
With this excellent introductory and first book focused on hybrid PET-MRI in neuroimag-
ing, the secret should be out. I can finally retire my lecture titled “PET-MRI will change neu-
roradiology practice” that I have given over the past 7 years on podcasts and at many US
institutions, national, and international meetings. When reading the chapters of this book, I
encourage readers to think about our collective future. We all may be anxious about “deep
learning” where clinical diagnosis and management are replaced by inscrutable layered algo-
rithms from Skynet based just on existing MRI protocols… yet all the deep learning in the
world could not solve the longitude navigation problem in the 1700s without an accurate clock
(i.e., the right data). PET tracers increase the dimensionality of imaging data and are already
being used to complement big data approaches to clinical imaging challenges in neurological
diseases. The underlying reality is that hybrid PET-MRI is already starting to transform imag-
ing for patients with neurological disease. It is not hard to see areas where imaging can improve
in 2021; the MS patient with stable-appearing MRI that no longer walks unassisted into their
follow-up scan, the young adult patient with smoldering autoimmune encephalitis or TBI that
everyone thinks is just depressed, or patients in the early stages of movement disorders with
normal-appearing MRI. Research with hybrid PET-MRI in carefully characterized clinical
patients should validate new biomarkers particularly with novel MRI contrasts and quantitative
approaches. MRI also transforms PET with dose reduction and increased spatial resolution
using joint reconstruction techniques. The development of new PET tracers will only acceler-
ate this holistic and synergistic process between two dynamic imaging technologies. Ana and
Dinko have picked the perfect time to create a book introducing us to this promising new
technology. I hope you find this book helpful and exciting for the future of diagnostic
neuroimaging.
References
1. Salamon et al. FDG-PET/MRI coegistration improves detection of cortical dysplasia in patients with
epilepsy. Neurology. 2008;71(20):1594-601.
2. Shaffer et al. Predicting cognitive decline in subjects at risk for Alzheimer’s disease by using combined cere-
brospinal fluid, MR imaging, and PET biomarkers. Radiology. 2013;266(2):583-91.
Contents
ix
x Contents
Part IV Epilepsy
Part V Neuro-Oncology
xv
xvi Contributors